Home Nucleus Biotechnology U.S. Bacteriophages Therapy Market to 2032

U.S. Bacteriophages Therapy Market to 2032

Overview

The U.S. Bacteriophages Therapy Market is expected to reach a 28.17 USD Million by 2032 and is projected to grow at a CAGR of 8.95% from 2025 to 2032.

Revenue, 2024 (USD Million)
18.18
Forecast, 2032 (USD Million)
28.17
CAGR, 2024 - 2032
8.95%
Report Coverage
U.S.

U.S. Bacteriophages Therapy Market 2018-2032 USD Million

U.S. Bacteriophages Therapy Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 18.18 USD Million
  • Projected Market Size (2032): 28.17 USD Million
  • CAGR (2025-2032): 8.95%

Key Findings of U.S. Bacteriophages Therapy Market

  • The U.S. Bacteriophages Therapy Market was valued at 18.18 USD Million in 2024.
  • The U.S. Bacteriophages Therapy Market is likely to grow at a CAGR of 8.95% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Lytic in Type Segment accounted for the largest share of the market with a revenue of 16.85 USD Million
  • The fastest growing segment Supperative Skin Infections in Application Segment grew Fastest with a CAGR of 9.64% during the forecast period from 2024 to 2032.

U.S. Bacteriophages Therapy Market Scope

U.S. Bacteriophages Therapy Market Segmentation & Scope
Type
  • Lysogenic
  • Lytic
Target
  • Salmonella
  • Streptococcus
  • Pseudomonas
  • Others
  • Escherichia coli
  • Staphylococcus
Base
  • Water-Soluble Jelly Base
  • Sterile Broth Culture
Distribution Channel
  • Third Party Distributors
  • Direct Tender
End User
  • Others
  • Academic Research & Institutes
  • Speciality Clinics
  • Hospitals
Route Of Administration
  • Others
  • Parenteral
  • Dermal
  • Oral
Application
  • Lung And Pleural Infections
  • Supperative Skin Infections
  • Others
  • Bacterial Dysentery
  • Infections Of Skin And Nasal Mucosa
  • Postoperative Wound Infections

U.S. Bacteriophages Therapy Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Million
Market Value in 2024 18.18 USD Million
Market Value in 2032 28.17 USD Million
CAGR (2025-2032) 8.95%
Historic Data 2016-2023
Market Segments Covered Type,Target,Base,Distribution Channel,End User,Route Of Administration,Application

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 18.18 USD Million in 2024
    • Key Country: U.S., leading in terms of revenue with value of 18.18 USD Million in 2024.

Segments and Scope

  • U.S. Bacteriophages Therapy Market to 2032, By Type
    • Lytic is the largest segment in U.S. Bacteriophages Therapy Market to 2032 with a revenue of 16.85 USD Million in the year 2024.
    • Lytic is the Fastest growing segment in U.S. Bacteriophages Therapy Market to 2032 with a Growth rate of 9.16 % in forecast period 2025-2032.
  • U.S. Bacteriophages Therapy Market to 2032, By Target
    • Staphylococcus is the largest segment in U.S. Bacteriophages Therapy Market to 2032 with a revenue of 4.82 USD Million in the year 2024.
    • Escherichia coli is the Fastest growing segment in U.S. Bacteriophages Therapy Market to 2032 with a Growth rate of 8.57 % in forecast period 2025-2032.
  • U.S. Bacteriophages Therapy Market to 2032, By Base
    • Sterile Broth Culture is the largest segment in U.S. Bacteriophages Therapy Market to 2032 with a revenue of 12.93 USD Million in the year 2024.
    • Sterile Broth Culture is the Fastest growing segment in U.S. Bacteriophages Therapy Market to 2032 with a Growth rate of 9.16 % in forecast period 2025-2032.
  • U.S. Bacteriophages Therapy Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.S. Bacteriophages Therapy Market to 2032 with a revenue of 16.31 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in U.S. Bacteriophages Therapy Market to 2032 with a Growth rate of 9.13 % in forecast period 2025-2032.
  • U.S. Bacteriophages Therapy Market to 2032, By End User
    • Hospitals is the largest segment in U.S. Bacteriophages Therapy Market to 2032 with a revenue of 7.24 USD Million in the year 2024.
    • Speciality Clinics is the Fastest growing segment in U.S. Bacteriophages Therapy Market to 2032 with a Growth rate of 8.59 % in forecast period 2025-2032.
  • U.S. Bacteriophages Therapy Market to 2032, By Route Of Administration
    • Oral is the largest segment in U.S. Bacteriophages Therapy Market to 2032 with a revenue of 8.33 USD Million in the year 2024.
    • Dermal is the Fastest growing segment in U.S. Bacteriophages Therapy Market to 2032 with a Growth rate of 8.63 % in forecast period 2025-2032.
  • U.S. Bacteriophages Therapy Market to 2032, By Application
    • Postoperative Wound Infections is the largest segment in U.S. Bacteriophages Therapy Market to 2032 with a revenue of 6.89 USD Million in the year 2024.
    • Supperative Skin Infections is the Fastest growing segment in U.S. Bacteriophages Therapy Market to 2032 with a Growth rate of 9.33 % in forecast period 2025-2032.

U.S. Bacteriophages Therapy Market Company Share Analysis

 
Company Name Company Share Analysis
Microgen
MICREOS
Intralytix, Inc.
LOCUS BIOSCIENCES, INC.
Phagelux, Inc.
U.S. Bacteriophages Therapy Market Company Share Analysis

U.S. Bacteriophages Therapy Market Geographical Sales Distribution, 2018-2032 USD Million

U.S. Bacteriophages Therapy Market Geographical Sales Distribution, 2018-2032 USD Million

U.S. Bacteriophages Therapy Market Company Profiling

U.S. Bacteriophages Therapy Market Company Profiling

Industry Related Reports

South America Cell And Gene Therapy Thawing Equipment Market
Middle East & Africa Cell And Gene Therapy Thawing Equipment Market
North America Cell And Gene Therapy Thawing Equipment Market
Europe Cell And Gene Therapy Thawing Equipment Market
Asia-Pacific Cell And Gene Therapy Thawing Equipment Market
Argentina Cell And Gene Therapy Thawing Equipment Market
Australia Cell And Gene Therapy Thawing Equipment Market
Belgium Cell And Gene Therapy Thawing Equipment Market
Brazil Cell And Gene Therapy Thawing Equipment Market
Canada Cell And Gene Therapy Thawing Equipment Market
Frequently Asked Questions
The U.S. Bacteriophages Therapy Market is segmented based on Segmentation Type,Target,Base,Distribution Channel,End User,Route Of Administration,Application.
U.S. Bacteriophages Therapy Market was valued at USD 18.18(Revenue in USD Million) in 2020.
U.S. Bacteriophages Therapy Market is projected to grow at a CAGR of 8.95% during the forecast period of 2024 to 2032.
The Lytic segment is expected to dominate the U.S. Bacteriophages Therapy Market, holding a largest market share of 16.85 USD Million in 2024

U.S. Bacteriophages Therapy Market Scope

U.S. Bacteriophages Therapy Market Segmentation & Scope
Type
  • Lysogenic
  • Lytic
Target
  • Salmonella
  • Streptococcus
  • Pseudomonas
  • Others
  • Escherichia coli
  • Staphylococcus
Base
  • Water-Soluble Jelly Base
  • Sterile Broth Culture
Distribution Channel
  • Third Party Distributors
  • Direct Tender
End User
  • Others
  • Academic Research & Institutes
  • Speciality Clinics
  • Hospitals
Route Of Administration
  • Others
  • Parenteral
  • Dermal
  • Oral
Application
  • Lung And Pleural Infections
  • Supperative Skin Infections
  • Others
  • Bacterial Dysentery
  • Infections Of Skin And Nasal Mucosa
  • Postoperative Wound Infections
Frequently Asked Questions
The U.S. Bacteriophages Therapy Market is segmented based on Segmentation Type,Target,Base,Distribution Channel,End User,Route Of Administration,Application.
U.S. Bacteriophages Therapy Market was valued at USD 18.18(Revenue in USD Million) in 2020.
U.S. Bacteriophages Therapy Market is projected to grow at a CAGR of 8.95% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Bacteriophages Therapy Market for final year is USD 28.17 (USD Million).

U.S. Bacteriophages Therapy Market Company Profiling

U.S. Bacteriophages Therapy Market Company Profiling
Frequently Asked Questions
The U.S. Bacteriophages Therapy Market is segmented based on Segmentation Type,Target,Base,Distribution Channel,End User,Route Of Administration,Application.
U.S. Bacteriophages Therapy Market was valued at USD 18.18(Revenue in USD Million) in 2020.
U.S. Bacteriophages Therapy Market is projected to grow at a CAGR of 8.95% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Bacteriophages Therapy Market for final year is USD 28.17 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES